BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12933671)

  • 21. Impairment of liver GH receptor signaling by fasting.
    Beauloye V; Willems B; de Coninck V; Frank SJ; Edery M; Thissen JP
    Endocrinology; 2002 Mar; 143(3):792-800. PubMed ID: 11861499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B.
    Stofega MR; Herrington J; Billestrup N; Carter-Su C
    Mol Endocrinol; 2000 Sep; 14(9):1338-50. PubMed ID: 10976913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between leptin and insulin signaling pathways differentially affects JAK-STAT and PI 3-kinase-mediated signaling in rat liver.
    Carvalheira JB; Ribeiro EB; Folli F; Velloso LA; Saad MJ
    Biol Chem; 2003 Jan; 384(1):151-9. PubMed ID: 12674509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated by stat5b.
    Zhou YC; Waxman DJ
    J Biol Chem; 1999 Jan; 274(5):2672-81. PubMed ID: 9915797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactogenic hormone-inducible phosphorylation and gamma-activated site-binding activities of Stat5b in primary rat Leydig cells and MA-10 mouse Leydig tumor cells.
    Kanzaki M; Morris PL
    Endocrinology; 1998 Apr; 139(4):1872-82. PubMed ID: 9528973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
    Le MN; Kohanski RA; Wang LH; Sadowski HB
    Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
    Banes AK; Shaw S; Jenkins J; Redd H; Amiri F; Pollock DM; Marrero MB
    Am J Physiol Renal Physiol; 2004 Apr; 286(4):F653-9. PubMed ID: 14678947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ethanol inhibits prolactin-induced activation of the JAK/STAT pathway in cultured astrocytes.
    DeVito WJ; Stone S
    J Cell Biochem; 1999 Aug; 74(2):278-91. PubMed ID: 10404396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin inhibits growth hormone signaling via the growth hormone receptor/JAK2/STAT5B pathway.
    Ji S; Guan R; Frank SJ; Messina JL
    J Biol Chem; 1999 May; 274(19):13434-42. PubMed ID: 10224108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Noncanonical suppression of GH-dependent isoforms of cytochrome P450 by the somatostatin analog octreotide.
    Das RK; Banerjee S; Shapiro BH
    J Endocrinol; 2013 Jan; 216(1):87-97. PubMed ID: 23077183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aryl hydrocarbon receptor-mediated suppression of GH receptor and Janus kinase 2 expression in mice.
    Nukaya M; Takahashi Y; Gonzalez FJ; Kamataki T
    FEBS Lett; 2004 Jan; 558(1-3):96-100. PubMed ID: 14759523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The functional role of the JAK-STAT pathway in post-infarction remodeling.
    El-Adawi H; Deng L; Tramontano A; Smith S; Mascareno E; Ganguly K; Castillo R; El-Sherif N
    Cardiovasc Res; 2003 Jan; 57(1):129-38. PubMed ID: 12504822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
    Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
    Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma growth hormone pulse activation of hepatic JAK-STAT5 signaling: developmental regulation and role in male-specific liver gene expression.
    Choi HK; Waxman DJ
    Endocrinology; 2000 Sep; 141(9):3245-55. PubMed ID: 10965895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired JAK-STAT signal transduction contributes to growth hormone resistance in chronic uremia.
    Schaefer F; Chen Y; Tsao T; Nouri P; Rabkin R
    J Clin Invest; 2001 Aug; 108(3):467-75. PubMed ID: 11489940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytochrome P450 2C11 5'-flanking region and promoter: regulation by aromatic hydrocarbons in vitro.
    Sawaya RM; Riddick DS
    Toxicology; 2008 Jun; 248(2-3):104-12. PubMed ID: 18440119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone-mediated janus associated kinase-signal transducers and activators of transcription signaling in the growth hormone-resistant potassium-deficient rat.
    Schaefer F; Yoon SA; Nouri P; Tsao T; Tummala P; Deng E; Rabkin R
    J Am Soc Nephrol; 2004 Sep; 15(9):2299-306. PubMed ID: 15339979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.
    Huang JS; Guh JY; Hung WC; Yang ML; Lai YH; Chen HC; Chuang LY
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):231-8. PubMed ID: 10432321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-1 inhibits the induction of insulin-like growth factor-I by growth hormone in CWSV-1 hepatocytes.
    Shumate ML; Yumet G; Ahmed TA; Cooney RN
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G227-39. PubMed ID: 15831712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells.
    Morales O; Lindgren U; Haldosén LA
    J Bone Miner Res; 2000 Nov; 15(11):2284-90. PubMed ID: 11092411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.